Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig

Journal of Lipid Research

Volumn 37, Issue 11, 1996, Pages 2372-2382

  Conde, Karin ^a   Vergara Jimenez, Marcela ^a   Krause, Brian R ^b   Newton, Roger S ^b   Fernandez, Maria Luz ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b PFIZER INC   (United States)

Author keywords

ACAT; apoB secretion rates; atorvastatin; guinea pig; HMG CoA reductase inhibitors; LDL

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; ATORVASTATIN; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; FAT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LAURIC ACID; LIPID; LIPOPROTEIN; LIPOPROTEIN RECEPTOR; LIVER ENZYME; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYRISTIC ACID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

AFFINITY CHROMATOGRAPHY; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; GUINEA PIG; HYPERCHOLESTEROLEMIA; IMMUNODIFFUSION; LIVER; LIVER MICROSOME; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CHOLESTEROL, LDL; GUINEA PIGS; HEPTANOIC ACIDS; LIPIDS; LIPOPROTEINS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; LIVER; MALE; MICROSOMES, LIVER; PYRROLES; RECEPTORS, LIPOPROTEIN; TRIGLYCERIDES;

EID: 0030454106     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Dalen, J. E. 1991. National Cholesterol Education Program. Report of the expert Panel on Population Strategies for Blood Cholesterol Reduction: Executive Summary. Arch. Intern. Med. 151: 1071-1083.
2. Davignon, J., M. Montigny, and R. Dufour. 1992. HMG-CoA reductase inhibitors: a look back and a look ahead. Can. J. Cardiol. 8: 843-864.
3. Endo, A. 1992. The discovery and development of HMG-CoA reductase inhibitors. J. Lipid Res. 33: 1569-1582.
4. Kasim, S. E., R. C. LeBoeuf, S. Khilnani, L. Tallapaka, D. Dayananda, and K. L. Jen. 1992. Mechanisms of triglyceride-lowering effect on an HMG-CoA reductase inhibitor in a hypertriacylglyceridemic animal model, the Zucker obese rat. J. Lipid Res. 33: 1-7.
5. Kasiske, B. L., M. P. O'Donnell, Y. Kim, D. Atluru, and W. F. Keane. 1994. Cholesterol synthesis inhibitors inhibit more than cholesterol synthesis. Kidney Int. 45: S51-S53.
6. Bocan, T. M. A., M. J. Mazur, S. B. Mueller, E. Q. Brown, D. R. Sliskovic, P. M. O'Brien, M. W. Creswell, H. Lee, P. D. Uhlendorf, B. D. Roth, and R. S. Newton. 1994. Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation. Atherosclerosis. 111: 127-142.
7. Homma, Y., H. Ozawa, T. Kobayashi, H. Yamaguchi, H. Sakane, and H. Nakamura. 1995. Effects of simvastatin on plasma lipoprotein subfractions, cholesterol esterification rate, and cholesteryl ester transfer protein in type II hyperlipoproteinemia. Atherosclerosis. 114: 223-234.
8. Krause, B. R., and R. S. Newton. 1991. Animal models for the evaluation of inhibitors of HMG-CoA reductase. Adv. Lipid Res. 1: 57-72.
9. Nawrocki, J. W., S. R. Weiss, M. H. Davidson, D. L. Sprecher, S. L. Schwartz, P. J. Lupien, P. H. Jones, H. E. Haber, and D. M. Black. 1995. Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler. Thromb. Vasc. Biol. 15: 678-682.
10. Bocan, T. M., S. BakMueller, W. Rosebury, P. Lee, E. QuenbyBrown, M. J. Mazur, and B. R. Krause. 1995. Anti-atherosclerotic and hypolipidemic activity of atorvastatin, an HMG-CoA reductase inhibitor, and CI-976, an ACAT inhibitor, when administered in combination. XII International Symposium on Drugs Affecting Lipid Metabolism. Abstracts: 42.
11. Auerbach, B. J., B. R. Krause, C. L. Bisgaier, and R. S. Newton. 1995. Comparative effects of HMG-CoA reductase inhibitors on apoB production in the casein-fed rabbit: atorvastatin versus lovastatin. Atherosclerosis. 115: 173-180.
12. Burnett, J. R., D. E. Telford, S. J. Kleinstiver, P. H. R. Barrett, R. S. Newton, and M. W. Huff. 1995. Atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs. XII International Symposium on Drugs Affecting Lipid Metabolism. Abstracts: 115.
13. Macri, J., A. Mohammadi, R. S. Newton, and K. Adeli. 1995. Effect of atorvastatin on intracellular translocation and degradation of apolipoprotein B in permeabilized HepG2 cells. XII International Symposium on Drugs Affecting Lipid Metabolism. Abstracts: 53.
14. Lin, E. C. K., M. L. Fernandez, and D. J. McNamara. 1992. Dietary cholesterol and fat quantity interact to affect cholesterol metabolism in guinea pigs. J. Nutr. 120: 1037-1045.
15. Redgrave, T., C. Roberts, and G. West. 1975. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal. Biochem. 65: 42-49.
16. Redgrave, T., and L. A. Carlson. 1979. Changes in plasma very low density and low density lipoprotein content, composition, and size after a fatty meal in normo- and hypertriglyceridemic man. J. Lipid Res. 20: 217-229.
17. Allain, C., L. Poon, C. Chan, W. Richmond, and P. Fu. 1974. Enzymatic determination of total serum cholesterol. Clin. Chem. 20: 470-475.
18. Warnick, G., J. Benderson, and J. Albers. 1982. Dextran sulfate-Mg precipitation procedure for quantification of HDL cholesterol. Clin. Chem. 28: 1379-1388.
19. Carr, T. P., G. J. Andersen, and L. L. Rudel. 1993. Enzymatic determination of triglycerides, free cholesterol, and total cholesterol in tissue lipid extracts. Clin. Chem. 26: 39-42.
20. Folch, J., M. Lees, G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 497-509.
21. Ishida, B. Y., and B. Paigen. 1992. Silver-enhanced radial immunodiffusion assay of plasma apolipoproteins. J. Lipid Res. 33: 1073-1077.
22. Markwell, M. A., S. Haas, L. Bieber, and N. E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87: 206-210.
23. Van Heek, M., and D. Zilversmit. 1991. Mechanisms of hypertriglyceridemia in the coconut oil/cholesterol-fed rabbit: increased secretion and decreased catabolism of very low density lipoprotein. Atheroscler. Thromb. 11: 918-927.
24. Fernandez, M. L., D. M. Sun, C. Montano, and D. J. McNamara. 1995. Carbohydrate-fat exchange and regulation of hepatic cholesterol and plasma lipoprotein metabolism in the guinea pig. Metabolism. 44: 855-864.
25. Fernandez, M. L., and D. J. McNamara. 1989. Dietary fat-mediated changes in hepatic apoB/E receptors in the guinea pig: effects of polyunsaturated, monounsaturated and saturated fat. Metabolism. 38: 1094-1102.
26. Goldstein, J. L., S. K. Basu, and M. S. Brown. 1983. Receptor-mediated endocytosis of low density lipoprotein in cultured cells. Methods Enzymol. 98: 241-260.
27. Fernandez, M. L., D. M. Sun, M. Tosca, and D. J. McNamara. 1994. Citrus pectin and cholesterol interact to regulate hepatic cholesterol homeostasis and lipoprotein metabolism: a dose-response study in guinea pigs. Am. J. Clin. Nutr. 61: 869-878.
28. Keightley, D. D., R. J. Fischer, and N. A. C. Cressie. 1983. Properties and interpretation of the Woolf and Scatchard plots in analyzing data from steroid receptor assays. J. Steroid Biochem. 9: 1407-1412.
29. Shapiro, D. L., R. L. Imblum, and V. W. Rodwell. 1969. Thin-layer chromatographic assay for HMG-CoA reductase and mevalonic acid. Anal. Biochem. 31: 383-390.
30. Smith, J. L., J. Jersey, S. P. Pillay, and I. R. Hardie. 1986. Hepatic acyl-CoA: cholesterol acyltransferase. Development of a standard assay and determination in patients with cholesterol gallstones. Clin. Chim. Acta. 158: 271-282.
31. Jelinek, D. F., S. Andersson, C. A. Slaughter, and D. Russell. 1990. Cloning and regulation of cholesterol 7α-hydroxylase, the rate limiting enzyme in bile acid biosynthesis. J. Biol. Chem. 265: 8190-8197.
32. Otway, S., and D. S. Robinson. 1967. The use of nonionic detergent (Triton WR-1339) to determine triglyceride entry into the circulation of the rat under different conditions. J. Physiol. 196: 321-332.
33. Egusa, G., D. W. Brady, S. M. Grundy, and B. V. Howard. 1983. Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein. J. Lipid Res. 24: 1261-1267.
34. Bocan, T. M., E. Ferguson, W. McNally, P. D., Uhlendorf, S. Mueller, P. Dehart. D. R. Sliskovic, B. D. Roth, B. R. Krause, and R. S. Newton. 1992. Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors. Biochim. Biophys. Acta. 1123: 1330-1344.
35. Ciaravino V., M. L. Kropko, C. E. Rothwell, C. A. Hovey, and J. C. Theiss. 1995. The genotoxicity profile of atorvastatin, a new drug in the treatment of hypercholesterolemia. Mutation Res. 343: 95-107.
36. Berglund, L., M. F. Sharkey, R. L. Elam, and J. L. Witztum. 1989. Effects of lovastatin therapy on guinea pig low density lipoprotein composition and metabolism. J. Lipid Res. 30: 1591-1600.
37. Krause, B. R., and R. S. Newton. 1995. Lipid-lowering activity of atorvastatin and lovastatin in rodent species: triglyceride-lowering in rats correlates with efficacy in LDL animal models. Atherosclerosis. 117: 237-244.
38. Ahnadi, C. E., F. Berthezene, and G. Ponsin. 1993. Simvastatin-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins in normolipidemis subjects. Atherosclerosis. 99: 219-228.
39. Witztum, J. L., S. G. Young, R. L. Elam, T. E. Carew, and M. Fisher. 1985. Cholestyramine-induced changes in low density lipoprotein composition and metabolism. 1. Studies in the guinea pig. J. Lipid Res. 26: 92-103.
40. Huff, M. W., D. E. Telford, P. H. R. Barrett, J. T. Billheirner, P. J. Gillies. 1994. Inhibition of hepatic ACAT decreases apoB secretion in miniature pigs fed a cholesterol-free diet. Arterioscler. Thromb. 14: 1498-1508.
41. Fujioka, T., F. Nara, Y. Tsujita, J. Fukushige, M. Fukami, and M. Kuroda. 1995. The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglytaryl coenzyme A reductase inhibitor, in rats. Biochim. Biophys. Acta. 1254: 7-12.
42. Nguyen, L. B., S. Shefer, G. Salen, G. C. Ness, A. Batta. I. R. Chowdhary, E. Paroulek, and S. Hauser. 1994. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in the rat ilium: effects of bile acids and lovastatin. Metabolism. 43: 1446-1450.
43. Suckling, K. E., and E. Stange. 1985. Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism. J. Lipid Res. 26: 647-671.
44. Carr, T. P., J. S. Parks, and L. L. Rudel. 1992. Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis. Arterioscler. Thromb. 12: 1274-1283.
45. Shand, J. H., and D. W. West. 1995. The effects of simvastatin and cholestyramine, alone and in combination, on hepatic cholesterol metabolism in the male rat. Lipids. 30: 917-926.
46. Elovson, J., J. E. Chatterton, G. T. Bell, V. N. Schumaker, M. A. Reuben, D. L. Puppione, J. R. Reeve, Jr., and N. L. Young. 1988. Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J. Lipid Res. 29: 1461-1473.
47. Ginsberg, H. N. 1990. Lipoprotein physiology and its relationship to atherogenesis. Endocrinol. Metab. Clin. North Am. 19: 211-227.